Alpha 2.0
Login Register
» Authors » Alexander Berkowitsch

Alexander Berkowitsch

Explore the profile of Alexander Berkowitsch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 1003
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Physiology
General Medicine
Top 10 Co-Authors
Thomas Neumann
Malte Kuniss
Christian W Hamm
Maciej Wojcik
Harald Greiss
Heinz F Pitschner
Sergey Zaltsberg
Johannes Sperzel
Damir Erkapic
Sergej Zaltsberg
Published In
Pacing Clin Electrophysiol
Europace
J Cardiovasc Electrophysiol
Int J Cardiol
Clin Res Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Pulmonary Vein Isolation Followed by Biatrial Ablation of Rotational Activity in Patients with Persistent Atrial Fibrillation: Results of the Cryo-Vest Study
Weipert K, Hutter J, Kuniss M, Kahle P, Yogarajah J, Hain A, et al.
J Clin Med . 2024 Feb; 13(4). PMID: 38398432
: Noninvasive mapping allows the identification of patient-specific atrial rotational activity (RA) that might play a key role in the perpetuation of persistent atrial fibrillation (PsAF). So far, the impact...
2.
Personalised preinterventional risk stratification of mortality, length of stay and hospitalisation costs in transcatheter aortic valve implantation using a machine learning algorithm: a pilot trial
Zisiopoulou M, Berkowitsch A, Redlich L, Walther T, Fichtlscherer S, Leistner D
Open Heart . 2024 Feb; 11(1). PMID: 38388188
Introduction: Risk stratification based on Euroscore II (ESII) is used in some centres to assist decisions to perform transcatheter aortic valve implant (TAVI) procedures. ESII is a generic, non-TAVI-specific metric,...
3.
Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement
Mas-Peiro S, Abplanalp W, Rasper T, Berkowitsch A, Leistner D, Dimmeler S, et al.
Eur Heart J . 2023 Mar; 44(21):1943-1952. PMID: 36932691
Aims: Mosaic loss of Y chromosome (LOY) in blood cells is the most common acquired mutation, increases with age, and is related to cardiovascular disease. Loss of Y chromosome induces...
4.
Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR
Mas-Peiro S, Pergola G, Berkowitsch A, Meggendorfer M, Rieger M, Vasa-Nicotera M, et al.
Clin Res Cardiol . 2023 Jan; 112(5):585-593. PMID: 36680616
Background: Mutations in the clonal hematopoiesis of indeterminate potential (CHIP)-driver genes DNMT3A and TET2 have been previously shown to be associated with short-term prognosis in patients undergoing TAVR for aortic...
5.
Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement
Hoffmann J, Tabata N, Mas-Peiro S, Spyridopoulos I, Sinning J, Berkowitsch A, et al.
Eur Heart J Open . 2022 Aug; 2(4):oeac045. PMID: 35983406
Aims: Inflammatory activation of leukocytes may limit prognosis of patients (pts) with severe aortic valve stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Leukocyte telomere length (LTL) is a marker...
6.
Personalized Preoperative Prediction of the Length of Hospital Stay after TAVI Using a Dedicated Decision Tree Algorithm
Zisiopoulou M, Berkowitsch A, Neuber R, Gouveris H, Fichtlscherer S, Walther T, et al.
J Pers Med . 2022 Mar; 12(3). PMID: 35330346
Background: The aim of this study was to identify pre-operative parameters able to predict length of stay (LoS) based on clinical data and patient-reported outcome measures (PROMs) from a scorecard...
7.
A Novel Method to Predict Mortality and Length of Stay after Transfemoral Transcatheter Aortic Valve Implantation
Zisiopoulou M, Berkowitsch A, Seppelt P, Zeiher A, Vasa-Nicotera M
Medicina (Kaunas) . 2021 Dec; 57(12). PMID: 34946277
: We tested if a novel combination of predictors could improve the accuracy of outcome prediction after transfemoral transcatheter aortic valve implantation (TAVI). : This prospective study recruited 169 participants...
8.
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
Cremer S, Pilgram L, Berkowitsch A, Stecher M, Rieg S, Shumliakivska M, et al.
PLoS One . 2021 Oct; 16(10):e0258684. PMID: 34673795
Aims: Patients with cardiovascular comorbidities have a significantly increased risk for a critical course of COVID-19. As the SARS-CoV2 virus enters cells via the angiotensin-converting enzyme receptor II (ACE2), drugs...
9.
Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality
Kiefer K, Cremer S, Pardali E, Assmus B, Abou-El-Ardat K, Kirschbaum K, et al.
ESC Heart Fail . 2021 Mar; 8(3):1873-1884. PMID: 33779075
Aims: Somatic mutations in haematopoietic stem cells can lead to the clonal expansion of mutated blood cells, known as clonal haematopoiesis (CH). Mutations in the most prevalent driver genes DNMT3A...
10.
Potential Role and Prognostic Value of Erythropoietin Levels in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Mas-Peiro S, Seppelt P, de Rosa R, Murray M, Yogarajah J, Berkowitsch A, et al.
Front Cardiovasc Med . 2020 Dec; 7:605257. PMID: 33330669
Both EPO levels and anemia have shown prognostic value in several cardiac disorders. An observational study with a prospective follow-up was performed to investigate their independent prognostic roles in severe...